CORC

浏览/检索结果: 共50条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2 会议论文
作者:  Knox, J.;  Cheng, A.;  Cleary, S.;  Galle, P.;  Kokudo, N.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
A Phase IIIb Trial of Afatinib in EGFRm plus NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC) 会议论文
作者:  Wu, Y.;  Chang, J.;  Zhang, L.;  Tu, H.;  Wu, L.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Phase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer 会议论文
作者:  Jiang, Z.;  Li, W.;  Hu, X.;  Zhang, Q.;  Sun, T.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs) 会议论文
作者:  Soo, R.;  Mok, T. S. K.;  Shi, Y-K.;  Zhang, L.;  Lu, S.
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/05
Assessing right ventricular morphological changes and dysfunction on long-term lymphoma survivors received anthracycline by three-dimensional speckle tracking echocardiography 会议论文
作者:  Shu, X. H.;  Ge, J. B.;  Zhang, C. J.;  Cheng, L. L.;  Xu, Y. C.
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
Early trend of right ventricular dysfunction on patients with lymphoma received high dose of anthracycline therapy 会议论文
作者:  Song, F. Y.;  Cheng, L. L.;  Zhang, C. J.;  Xu, Y. C.;  Shu, X. H.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naive Patients with EGFRm plus NSCLC: An Interim Analysis 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
afatinib  EGFR  NSCLC  
The Evidence Driven Dosimetric Constraints From Outcome Analysis of H&N Patients' Data from NRG Oncology RTOG 0522 Trial 会议论文
作者:  Zhong, H.;  Wang, J.;  van Soest, J.;  Geng, H.;  Huang, M.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
The Predictive T1 MR Radiomics Features for the Outcome of Locally Advanced Rectal Cancer Patients 会议论文
作者:  Zhong, H.;  Boimel, P.;  Fan, Y.;  Wang, J.;  Geng, H.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace